Ingun Ståhl
-
Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase
inhibitors
Viktor Sandblom, Johan Spetz, Emman Shubbar, Mikael Montelius, Ingun Ståhl, John Swanpalmer, Ola Nilsson, Eva Forssell-Aronsson
PLoS ONE - 2020 -
Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid
cancer.
Viktor Sandblom, Johan Spetz, Emman Shubbar, Mikael Montelius, Ingun Ståhl, John Swanpalmer, Ola Nilsson, Eva Forssell-Aronsson
PloS One - 2019 -
Tyrosine kinase inhibitors can potentially increase the effect from radiation therapy on medullary thyroid
cancer
Viktor Sandblom, Johan Spetz, Emman Shubbar, Mikael Montelius, Ingun Ståhl, John Swanpalmer, Ola Nilsson, Eva Forssell-Aronsson
Gothenburg Cancer Meeting. 6-7th May 2019 - 2019 -
Tyrosinkinashämmare kan öka effekten från strålbehandling av medullär
tyreoideacancer
Viktor Sandblom, Johan Spetz, Emman Shubbar, Mikael Montelius, Ingun Ståhl, John Swanpalmer, Ola Nilsson, Eva Forssell-Aronsson
Nationellt möte om sjukhusfysik - 2019 -
Clinical feasibility and positional stability of an implanted wired transmitter in a novel electromagnetic positioning system for prostate cancer
radiotherapy.
Karin Braide, Ulrika Lindencrona, Kristina Welinder, Julia Götstedt, Ingun Ståhl, Niclas Pettersson, Jon Kindblom
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 2018 -
Vandetanib may act as radiosensitiser for 177Lu-octreotate treatment of medullary thyroid
cancer
Viktor Sandblom, Johan Spetz, Emman Shubbar, Ingun Ståhl, John Swanpalmer, Eva Forssell-Aronsson
2nd European Congress of Medical Physics. Physica Medica Vol. 52, Suppl. 1, pp. 62-63 - 2018